Marks, David R <br/><br/>
Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  May 2009 
 - 6734-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Standard No.: </label>10.1523/JNEUROSCI.1350-09.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Animals<br/>Animals, Newborn<br/>Anxiety--chemically induced<br/>Behavior, Animal--drug effects<br/>Blood Glucose--drug effects<br/>Brain Chemistry--drug effects<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--administration & dosage<br/>Kv1.3 Potassium Channel--metabolism<br/>Male<br/>Memory--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Obesity--drug therapy<br/>Olfactory Mucosa--drug effects<br/>Olfactory Pathways--drug effects<br/>Phosphorylation--drug effects<br/>Receptors, Odorant--genetics<br/>Sensory Thresholds--drug effects<br/>Smell--drug effects<br/>Time Factors<br/>Tyrosine--metabolism<br/>Wakefulness<br/>tau Proteins--genetics